Trademark: 98256227
Word
LIQUI SRS
Status Date
Wednesday, September 18, 2024
Filing Date
Monday, November 6, 2023
5 Pharmaceutical drugs for the treatment and prevention of chronic and non-chronic diseases; Drug delivery agents in particular sustained release agents in the form of capsules and tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drugs for medical for purposes in particular sustained release drug formulations for the treatment and prevention of chronic and non-chronic diseases.
42 Drug discovery services; biological research; clinical research in the medical, pharmaceutical, and biotechnology fields; medical research; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development in the pharmaceutical and biotechnology fields for the pharmaceutical industry; pharmaceutical products development; pharmaceutical formulation in the nature of pharmaceutical products development; biomedical research services; medical and scientific research in the field of pharmacogenetics; research and development of vaccines and medicines; pharmaceutical drug development services; development of pharmaceutical preparations in particular sustained release formulations and medicines; pharmaceutical research services.
Nov 9, 2023
New Application Entered
Jun 14, 2024
Assigned To Examiner
Jun 26, 2024
Non-Final Action Written
Jun 26, 2024
Notification Of Non-Final Action E-Mailed
Jun 26, 2024
Non-Final Action E-Mailed
Jul 31, 2024
Teas Response To Office Action Received
Nov 30, 2023
New Application Office Supplied Data Entered
Jul 31, 2024
Correspondence Received In Law Office
Jul 31, 2024
Teas/Email Correspondence Entered
Sep 18, 2024
Non-Final Action E-Mailed
Sep 18, 2024
Notification Of Non-Final Action E-Mailed
Sep 18, 2024
Non-Final Action Written
Trademark Alertz updated from USPTO on 2030-01-24
